Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Нyperlactatemia in patients cardiac surgery аnd its correlation with subsequent changes in laboratory parameters in the early postoperative period

Authors: Samuilova D.Sh., Lobacheva G.V., Rakhimov A.A., Kolesnikova E.A., Samorodskaya I.V., Borovkova U.L., Linenko O.N., Rogal’skaya E.A., Skopin I.I., Bockeria L.A.

Company:
A.N. Bakoulev Scientific Center for Cardiovascular Surgery, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

Link: Clinical Physiology of Blood Circulaiton. 2014; (): -

Quote as: Samuilova D.Sh., Lobacheva G.V., Rakhimov A.A., Kolesnikova E.A., Samorodskaya I.V., Borovkova U.L., Linenko O.N., Rogal’skaya E.A., Skopin I.I., Bockeria L.A. Нyperlactatemia in patients cardiac surgery аnd its correlation with subsequent changes in laboratory parameters in the early postoperative period. Klinicheskaya Fiziologiya Krovoobrashcheniya. 2014; 3: 12-23.

Full text:  

Abstract

Objective of the research – to estimate correlation between hyperlactatemia and changes in laboratory parameters reflecting multiple organ failure in the early stages of the postoperative period.
Material and methods. The authors retrospectively examined 103 patients undergoing cardiac surgery with cardiopul- monary bypass.
Results. Various changes in blood biochemical parameters were observed in patients in early stages of the postoperative period. These changes depended on level of hyperlactatemia. High level of creatinine, aspartate aminotransferase, alanine aminotransferase, amylase, urea and low level of protein and albumin were characteristics for the patients with high level of hyperlactatemia.
Conclusion. Our results indicate that biochemical signs of renal dysfunction, liver failure, damage of pancreatic cells and cardiomyocytes are most pronounced in patients with hyperlactatemia. Hyperlactatemia is one of the warning signs of possible postoperative complications forthcoming. Screening laboratory tests could be used to predict and/or evaluate the beginning of serious problems.

References

1. Jansen T.C., van Bommel J., Woodward R., Mulder P.G., Bak- ker J.A. Association between blood lactate levels. Sequential organ failure assessment subcores, and 28-day mortality during early and late intensive care unit stay: a retrospective observation- al study. Crit. Care Med. 2009; 37 (8): 2369–74.
2. Badreldin A.M., Doerr F., Brehm B.R., Abul-Dahab M., Lehmann T., Bayer O. et al. Mortality prediction after cardiac sur- gery: blood lactate is indispensible. Thorac. Cardiovasc. Surg. 2013; 61 (8): 708–17.
3. Hajjar L.A., Almeida J.P., Fukushima J.T., Rhodes A., Vin- cent J.L., Osawa E.A., Galas F.R. High lactate levels are predic- tors of major complications after cardiac surgery. J. Thorac. Cardiovasc. Surg. 2013; 146 (2): 455–60.
4. Jabarri A., Banihashem N., Alijanpour E., Vafaey H.R., Alere- za H., Rabiee S.M. Serum lactate as a prognostic factor in coro- nary artery bypass graft operation by on pump method. Caspian. J. Intern. Med. 2013; 4 (2): 662–6.
5. Kogan A., Preisman S., Bar A., Stemic L., Lavee J., Malachy A. et al. The impact of hyperlactatemia on postoperative outcome after adult cardiac surgery. J. Anesth. 2012; 26 (2): 174–8.
6. Бокерия Л.А., Самородская И.В., Самуилова Д.Ш., Боров- кова У.Л. Гематологические и биохимические предикторы течения послеоперационного периода у кардиохирургичес- ких больных (ретроспективное исследование). Клиническая физиология кровообращения. 2012; 4: 25–30.
7. Habib R.H., Zacharias A., Schwann T.A., Riordan C.J., Dur- ham S.J., Shah A. Adverse effects of low hematocrit during car- diopulmonary bypass in the adult: should current practice be changed? J. Thorac. Cardiovasc. Surg. 2003; 125 (6): 1438–50.
8. Ranucci M., Isgro` G., Romitti F., Mele S., Biagioli B., Gio- marelli P. Anaerobic metabolism during cardiopulmonary bypass: predictive value of carbon dioxide derived parameters. Ann. Thorac. Surg. 2006; 81 (6): 2189–95.
9. Moguel-González B., Wasung-de-Lay M., Tella-Vega P., Riquel- me-Mc-Loughlin C., Villa A.R.,Madero M., Gamba G. Acute kidney injury in cardiac surgery. Rev. Invest. Clin. 2013; 65 (6): 467–75.
10. D’Onofrio A., Cruz D., Bolgan I., Auriemma S., Cresce G.D., Fabbri A., Ronco C. RIFLE criteria for cardiac surgery-associat- ed acute kidney injury: risk factors and outcomes. Congest. Heart Fail. 2010; 16 (Suppl. 1): S32–6.
11. Dasta J.F., Kane-Gill S.L., Durtschi A.J., Pathac D.S., Kell- um J.A. Costs and outcomes of acute kidney injury (AKI) follow- ing cardiac surgery. Nephrol. Dial. Transplant. 2008; 23: 1970–4.
12. Kumar A.B., Suneja M., Bayman E.O., Wiede G.D., Tarasi M. Association between postoperative acute kidney injury and dura- tion of cardiopulmonary bypass: a meta-analysis. J. Cardiothorac. Vasc. Anesth. 2012; 26 (1): 64–9.
13. Roh G.U., Lee J.W., Nam S.B., Lee J., Choi J.R., Shim Y.H. Inci- dence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann. Thorac. Surg. 2012; 94 (3): 766–71.
14. De Somer F., Mulholland J.W., Bryan M.R., Aloisio T., Van Nooten G.J., Ranucci M. O2 delivery and CO2 production during cardiopulmonary bypass as determinants of acute kidney injury: time for a goal-directed perfusion management? Crit. Care. 2011; 15 (4): R192.
15. Huybregts P.A., de Vroege R., Jansen E.K., van Schijndel A.W., Christiaans H.M., van Oeveren W. The association of hemodilu- tion and transfusion of red blood cells with biochemical markers of splanchnic and renal injury during cardiopulmonary bypass. Anesth. Analg. 2009; 109: 331–9.
16. Karkouti K., Beattie W.S., Wijeysundera D.N., Rao V., Chan C., Dattilo K.M. et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J. Thorac. Cardiovasc. Surg. 2005; 129: 391–400.
17. Liotta M., Olsson D., Sartipy U., Holzmann M.J. Minimal changes in postoperative creatinine values and early and late mor- tality and cardiovascular events after coronary artery bypass graft- ing. Am. J. Cardiol. 2014; 113 (1): 70–5.
18. Mao H., Katz N., Ariyanon W., Blanca-Martos L., Ady′bel- li Z.,Giuliani A. et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013; 3 (3): 178–99.
19. Hanssen S.J., Lubbers T., Hodin C.M., Princen F.W., Buur- man W.A., Jacobs M.J. Hemolysis results in impaired intestinal microcirculation and intestinal epithelial cell injury. World J. Gastroenterol. 2011; 17 (2): 213–8.
20. Mebazaa A., Pitsis A.A., Rudiger A., Toller W., Longrois D., Ricksten S.E. et al. Clinical review: practical recommendations on the management of perioperative heart failure in cardiac sur- gery. Crit. Care. 2010; 14 (2): 201.
21. Tritapepe L., De Santis V., Vitale D., Guarracino F., Pellegrini F., Pietropaoli P., Singer M. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft sur- gery. Br. J. Anaesth. 2009; 102 (2): 198–204.
22. Perez A., Ito H., Farivar R.S., Cohn L.H., Byrne J.G., Rawn J.D. et al. Risk factors and outcomes of pancreatitis after open heart surgery. Am. J. Surg. 2005; 190: 401–5.
23. Fernández-del Castillo C., Harringer W., Warshaw A.L., Via- hakes G.J., Koski G., Zaslavsky A.M. et al. Risk factors and out- comes of pancreatitis after open heart surgery. Am. J. Surg. 1991; 325: 382–7.
24. Chung J.W., Ryu S.H., Jo J.H., Park J.Y., Lee S., Park S.W. et al. Clinical implications and risk factors of acute pancreatitis after cardiac valve surgery. J. Med. Yonsei. 2013; 54 (1): 154–9.

 If you found mistakes, select text and press Alt+A